EMERYVILLE, Calif.--()--Amyris, Inc. (NASDAQ:AMRS) announced today that it has entered into an agreement with Givaudan (SIX:GIVN), the global leader in the fragrances and flavors industry, headquartered in Vernier, Switzerland. Under the agreement, Givaudan will develop a derivative of BiofeneTM to be used as a building block for one of the most important proprietary fragrance ingredients in Givaudan’s palette. Biofene is the chemical, farnesene, produced using Amyris’s bio-based technology and production platform.
“Our collaboration with Givaudan reinforces our commitment to supply No Compromise® solutions to the fragrances and flavors market”
The use of Biofene supports Givaudan’s goal of utilizing cost-effective and sustainably sourced materials. Upon successful achievement of certain success criteria, Amyris will supply Biofene to Givaudan to derive a proprietary fragrance ingredient for the global fragrances and flavors market. Givaudan intends to market and distribute the final product as early as 2012, and Amyris will share in the economic value created from the use of Biofene.
“Our collaboration with Givaudan reinforces our commitment to supply No Compromise® solutions to the fragrances and flavors market,” said John Melo, CEO of Amyris. “This project provides yet another example of the breadth of products that can be derived from Biofene - our first-to-market renewable building block.”
“As an innovator as well as the industry’s largest purchaser of raw materials, we have a responsibility to shape and lead the sustainability approach in the fragrances and flavors industry,” said Gilles Andrier, CEO of Givaudan. “Continued investment into research and development is a key pillar of our 5-year business strategy and through collaborations with suppliers like Amyris, we can deliver real and impactful solutions.”
Amyris’s synthetic biology platform creates living factories to produce specific, targeted molecules. Amyris’s technology platform may be applied to produce an array of ingredients currently used in the fragrances and flavors industry. Amyris designs its No Compromise products to provide high-quality solutions from sustainable and reliable sources and at competitive prices. This collaboration is another indication of Amyris’s potential in the fragrances and flavors market and is the first partnership that focuses on the use of Biofene as a building block for an important fragrances ingredient.
Amyris is an integrated renewable products company focused on providing sustainable alternatives to a broad range of petroleum-sourced products. Amyris uses its industrial synthetic biology platform to convert plant sugars into a variety of hydrocarbon molecules - flexible building blocks which can be used in a wide range of products. Amyris is commercializing these products both as No Compromise® renewable ingredients in cosmetics, fragrances and flavors, polymers, lubricants and consumer products, and also as No Compromise renewable diesel and jet fuel. Amyris Brasil S.A., a subsidiary of Amyris, oversees the establishment and expansion of Amyris’s production in Brazil. Amyris also has fuel distribution capabilities in the United States through its subsidiary, Amyris Fuels LLC. More information about Amyris is available at www.amyris.com.
As the leading company in the fragrance and flavor industry, Givaudan develops unique and innovative creations for its customers around the world. The company has approximately 25% market share, and this industry leadership position is underpinned by a sales and marketing presence in all major markets. Givaudan creates fragrances for personal and homecare brands that range from prestige perfumes to laundry care and, in flavors, the company's expertise spans beverages, savory, snacks, sweet goods and dairy products.
This release contains forward-looking statements, and any statements other than statements of historical facts could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events (such as statements regarding the parties expectations regarding the ability to successfully derive from Biofene and commercialize an ingredient for the fragrances and flavors market) that involve risks and uncertainties. These statements are based on management's current expectations and actual results and future events may differ materially due to risks and uncertainties, including those associated with any delays in production and commercialization of products and other risks detailed in the "Risk Factors" section of Amyris’s final prospectus for its initial public offering, as filed on September 28, 2010 pursuant to Rule 424(b) under the Securities Act of 1933, and its quarterly report on Form 10-Q filed on November 10, 2010. Amyris disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.
Amyris, Biofene and No Compromise are trademarks or registered trademarks of Amyris, Inc.